Related Experiment Videos
Redox metals and neurodegenerative disease
L M Sayre1, G Perry, M A Smith
1Department of Chemistry, Case Western Reserve University, Cleveland, OH44106, USA. LMS3@PO.CWRU.EDU
Current Opinion in Chemical Biology
|May 5, 1999
Summary
Redox-active transition metals contribute to oxidative stress in neurodegenerative diseases by binding to proteins. This binding can disrupt free radical balance, impacting disease progression.
Area of Science:
- Neuroscience
- Biochemistry
- Toxicology
Background:
- Oxidative stress is implicated in neurodegenerative diseases.
- Redox-active transition metals (e.g., copper, iron) play a role in oxidative stress.
- These metals interact with proteins relevant to neurodegeneration.
Purpose of the Study:
- To explore the role of transition metals in neurodegenerative disease pathogenesis.
- To understand how transition metals bind to neurodegeneration-associated proteins.
- To investigate the impact of metal-protein interactions on redox homeostasis.
Main Methods:
- Literature review of existing research on transition metals and neurodegeneration.
- Analysis of studies investigating metal binding to proteins like the prion protein.
- Examination of the effects of metal-protein interactions on protein redox activity.
Main Results:
- Transition metals bind to proteins associated with neurodegenerative diseases.
- Metal binding to the prion protein may have an antioxidant function.
- Adventitious metal binding to other proteins can preserve redox activity, disrupting homeostasis.
Conclusions:
- Transition metals are key mediators of oxidative stress in neurodegenerative conditions.
- Altered levels of copper and iron metalloenzymes contribute to redox imbalance.
- The precise role of transition metal homeostasis disruption in diseases like ALS requires further investigation.